shadow_tr

Krzysztof Moroz, MD

Krzysztof Moroz, M.D.

 

Professor
Director, Cytology Laboratory
Director, Cytopathology Fellowship
Co-Director, Biospecimen Core, Louisiana Cancer Research Consortium


Education

M.D., Academy of Medicine, Bialystok, Poland, 1984


Postgraduate Training and Fellowship

Anatomic Pathology, Mallory Institute of Pathology, Boston University School of Medicine, Boston MA, 1989-1991

Clinical Pathology, University Hospital, Boston University School of Medicine, Boston, MA, 1991-1993

Cytopathology, Mallory Institute of Pathology, Boston University School of Medicine, Boston, MA, 1993-1994


Specialty Certifications

1993, American Board of Pathology, Anatomic and Clinical Pathology

1994, American Board of Pathology, Cytopathology


Interests

Cytopathology and Surgical Pathology

Breast Cancer Pathology

GU/GYN Pathology

Prognostic Tumor Markers


Recent Publications

  1. Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, Rowan BG. A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies. BMC Cancer. 2012 Jan 10;12(1):10.

  2. Winters R, Friedlander P, Noureldine S, Ekaidi I, Moroz K, Kandil E. Preoperative parathyroid needle localization: a minimally invasive novel technique in reoperative settings. Minim Invasive Surg. 2011;2011:487076. Epub 2011 Aug 13.

  3. Bellows CF, Wheatley BM, Moroz K, Rosale SC, Morici LA. The Effect of Bacterial Infection on the Biomechanical Properties of Biological Mesh in a Rat Model. PLoS One. 2011;6(6):e21228. Epub 2011 Jun 16.

  4. Kandil E, Khalek MA, Alabbas H, Moroz K, Islam T, Friedlander P, Jaffe BM. Comparison of Ultrasound-Guided Biopsy Technique for Thyroid Nodules with Respect to Adequacy of Cytological Material. ORL J Otorhinolaryngol Relat Spec. 2011 May 27;73(4):177-181.

  5. Chakravarty G, Moroz K, Makridakis NM, Lloyd SA, Galvez SE, Canavello PR, Lacey MR, Agrawal K, Mondal D. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med (Maywood). 2011 Feb;236(2):145-55.

  6. Bao L, Haque A, Jackson K, Hazari S, Moroz K, Jetly R, Dash S. Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model. Am J Pathol. 2011 Feb;178(2):838-52.

  7. Winters A, Friedlander P, Jaffe BM, Khalek MA, Moroz K, Kandil E. Thyroid. A Postmenopausal Woman with Gross Cystic Disease Fluid Protein-15 and Estrogen Receptor-Positive Recurrence of Papillary Thyroid Cancer. Thyroid. 2010 Dec;20(12):1413-7. Epub 2010 Nov 7.

 

Dept. of Pathology & Laboratory Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 504-988-5224 tulpath@tulane.edu